Literature DB >> 10025408

Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.

M Huse1, Y G Chen, J Massagué, J Kuriyan.   

Abstract

Activation of the type I TGFbeta receptor (TbetaR-I) requires phosphorylation of a regulatory segment known as the GS region, located upstream of the serine/threonine kinase domain in the cytoplasmic portion of the receptor. The crystal structure of a fragment of unphosphorylated TbetaR-I, containing both the GS region and the catalytic domain, has been determined in complex with the FK506-binding protein FKBP12. TbetaR-I adopts an inactive conformation that is maintained by the unphosphorylated GS region. FKBP12 binds to the GS region of the receptor, capping the TbetaR-II phosphorylation sites and further stabilizing the inactive conformation of TbetaR-I. Certain structural features at the catalytic center of TbetaR-I are characteristic of tyrosine kinases rather than Ser/Thr kinases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025408     DOI: 10.1016/s0092-8674(00)80555-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  129 in total

1.  Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Mérino ewes.

Authors:  P Mulsant; F Lecerf; S Fabre; L Schibler; P Monget; I Lanneluc; C Pisselet; J Riquet; D Monniaux; I Callebaut; E Cribiu; J Thimonier; J Teyssier; L Bodin; Y Cognié; N Chitour; J M Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  A ligand-reversible dimerization system for controlling protein-protein interactions.

Authors:  C T Rollins; V M Rivera; D N Woolfson; T Keenan; M Hatada; S E Adams; L J Andrade; D Yaeger; M R van Schravendijk; D A Holt; M Gilman; T Clackson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.

Authors:  C S Mason; C J Springer; R G Cooper; G Superti-Furga; C J Marshall; R Marais
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 5.  Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).

Authors:  Jeffrey C Sivils; Cheryl L Storer; Mario D Galigniana; Marc B Cox
Journal:  Curr Opin Pharmacol       Date:  2011-04-19       Impact factor: 5.547

6.  Design and structure-based study of new potential FKBP12 inhibitors.

Authors:  Fei Sun; Pengyun Li; Yi Ding; Liwei Wang; Mark Bartlam; Cuilin Shu; Beifen Shen; Hualiang Jiang; Song Li; Zihe Rao
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

7.  Mapping protein pockets through their potential small-molecule binding volumes: QSCD applied to biological protein structures.

Authors:  Keith Mason; Nehal M Patel; Aric Ledel; Ciamac C Moallemi; Edward A Wintner
Journal:  J Comput Aided Mol Des       Date:  2004-01       Impact factor: 3.686

8.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

9.  Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Authors:  Feng Fang; Jiamao Zheng; Traci L Galbaugh; Alyson A Fiorillo; Elizabeth E Hjort; Xianke Zeng; Charles V Clevenger
Journal:  J Mol Endocrinol       Date:  2010-03-17       Impact factor: 5.098

10.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.